文献速递湿疹皮炎与荨麻疹

慢性手部湿疹的血浆炎症特征与病因及临床亚型的关联

Inflammatory plasma signature of chronic hand eczema: Associations with aetiological and clinical subtypes.
PubMed 文献 · J Eur Acad Dermatol Venereol · 2023-12-27

该研究检测了51例无特应性皮炎慢性手部湿疹患者和40名健康对照的266种炎症及心血管风险血浆蛋白及丝聚蛋白基因突变,发现严重慢性过敏性接触性皮炎手部表现与混合型1/2型系统免疫激活相关,且循环1/2型炎症生物标志物水平与临床严重度正相关;角化过度型慢性手部湿疹具有独特的非特应性皮炎样系统特征,以1型炎症和肿瘤坏死因子α相关标志物上调为主,CCL19和CXCL9/10水平升高可将其与囊疱型及慢性裂隙型区分。

要点

  • 严重慢性过敏性接触性皮炎手部表现与混合型1/2型系统免疫激活相关,支持其为系统性疾病。
  • 循环1/2型炎症生物标志物水平与过敏性接触性皮炎慢性手部湿疹的临床严重度正相关。
  • 角化过度型慢性手部湿疹具有独特系统特征,CCL19和CXCL9/10可将其与囊疱型及慢性裂隙型区分。

核心结论

  • 系统生物标志物分析有潜力识别特定慢性手部湿疹亚型。
  • 手部慢性过敏性接触性皮炎的循环炎症生物标志物水平与临床严重度相关,提示其为系统性疾病。
  • 研究对将角化过度型慢性手部湿疹归类为湿疹提出疑问。

研究设计与样本

  • 研究纳入51例无合并特应性皮炎的明确特征慢性手部湿疹患者和40名健康对照。
  • 检测266种炎症及心血管疾病风险血浆蛋白表达水平及丝聚蛋白基因突变状态。
  • 按病因和临床亚型分组比较血浆蛋白表达,并进行生物标志物与临床及自报变量的相关性分析。

主要发现

  • 与对照相比,手部极严重慢性过敏性接触性皮炎与混合型1/2型系统免疫激活相关。
  • 在过敏性接触性皮炎慢性手部湿疹患者中,循环1/2型炎症生物标志物水平与临床疾病严重度正相关。
  • 未发现能区分病因亚型(如过敏性接触性皮炎与刺激性接触性皮炎)的生物标志物。
  • 角化过度型慢性手部湿疹表现为独特的非特应性皮炎样系统特征,1型炎症和肿瘤坏死因子α相关标志物上调,但2型炎症标志物未上调。
  • CCL19和CXCL9/10水平升高可将角化过度型慢性手部湿疹与囊疱型及慢性裂隙型区分,而后两者间无差异。

临床怎么用

  • 对严重慢性过敏性接触性皮炎手部湿疹可考虑其系统炎症性质,关注循环1/2型炎症生物标志物与疾病严重度的关联。
  • CCL19和CXCL9/10或有助于从系统层面区分角化过度型与囊疱型及慢性裂隙型慢性手部湿疹。
  • 角化过度型慢性手部湿疹的系统特征提示其可能不应简单归类为湿疹,需进一步评估分类。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Chronic hand eczema (CHE) is a highly prevalent, heterogeneous, skin disease that encompasses different aetiological and clinical subtypes. Severe CHE without atopic dermatitis has been associated with systemic inflammation; yet it remains unknown if specific CHE subtypes leave distinct, systemic, molecular signatures. OBJECTIVES: To characterize the inflammatory plasma signature of different aetiological and clinical CHE subtypes. METHODS: We assessed expression levels of 266 inflammatory and cardiovascular disease risk plasma proteins as well as filaggrin gene mutation status in 51 well-characterized CHE patients without concomitant atopic dermatitis and 40 healthy controls. Plasma protein expression was compared between aetiological and clinical CHE subgroups and controls both overall and according to clinical CHE severity. Correlation analyses for biomarkers, clinical and self-reported variables were performed. RESULTS: Very severe, chronic allergic contact dermatitis (ACD) on the hands was associated with a mixed Type 1/Type 2 systemic immune activation as compared with controls. Circulating levels of Type 1/Type 2 inflammatory biomarkers correlated positively with clinical disease severity among CHE patients with ACD. No biomarkers were found, that could discriminate between aetiological subtypes, for example, between ACD and irritant contact dermatitis. Hyperkeratotic CHE showed a distinct, non-atopic dermatitis-like, systemic footprint with upregulation of markers associated with Type 1 inflammation and tumour necrosis factor alpha, but not Type 2 inflammation. Increased levels of CCL19 and CXCL9/10 could discriminate hyperkeratotic CHE from both vesicular and chronic fissured CHE, whereas no difference was found between the latter two subtypes. CONCLUSION: Profiling of systemic biomarkers showed potential for identifying certain CHE subtypes. Peripheral blood levels of inflammatory biomarkers were associated and correlated with the clinical disease severity of chronic ACD on the hands, underlining that this is a systemic disease. We question whether hyperkeratotic CHE should be classified as eczema.

来源:J Eur Acad Dermatol Venereol,查看原文。版权归原作者所有。

引用

  1. Quaade AS, Wang X, Sølberg JBK, et al. Inflammatory plasma signature of chronic hand eczema: Associations with aetiological and clinical subtypes. J Eur Acad Dermatol Venereol. 2023. PMID: 38151335. doi:10.1111/jdv.19742

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。